Find similar content

Source channel @githubtrending · Post #14751 · May 25

#c_lang#c#drivers#gpl#hacktoberfest#kernel#operating_system#os#osdev#reactos#win32#win32api#windows#x86 ReactOS is a free, open-source operating system designed to be compatible with Windows applications and drivers, especially those for Windows Server 2003 and later versions. The latest version, 0.4.15, brings major improvements like better USB and driver support, enhanced system stability, 64-bit fixes, and new features in system tools such as Notepad and Paint. It can be tested safely on virtual machines and is ideal for users seeking a Windows-like experience without Microsoft’s software. ReactOS is still in alpha, so it’s best for testing, but it offers a promising alternative for Windows users wanting a free, open-source OS[1][2][3]. https://github.com/reactos/reactos

Hashtags

#c_lang #c #drivers #gpl #hacktoberfest #kernel #operating_system #os #osdev #reactos #win32 #win32api #windows #x86

Results

2 similar posts found

Search: #drugdevelopment

当前筛选 #drugdevelopment清除筛选

Crypto M - Crypto News

@CryptoM · Post #64470 · 04/09/2026, 01:45 AM

Find similar View

🚀 Hong Kong's Innovative Drug Sector Gains Momentum Hong Kong's innovative drug sector is experiencing a surge, with several companies showing significant gains. According to Jin10, Ascletis Pharma (01672.HK) saw an increase of over 3%, while Hansoh Pharmaceutical (03692.HK) rose by more than 2%. Other companies such as WuXi AppTec (02359.HK) and Sihuan Pharmaceutical (00460.HK) also followed suit with upward trends. #HongKong#Pharmaceuticals#Biotech#Innovation#StockMarket#Healthcare#DrugDevelopment

Hashtags

#hongkong #pharmaceuticals #biotech #innovation #stockmarket #healthcare #drugdevelopment

Venture Village Wall 🦄

@venturevillagewall · Post #3642 · 12/21/2024, 10:23 AM

Find similar View

PeproMene Bio Secures $11M Round PeproMene Bio, Inc., a clinical-stage biotech firm based in Irvine, CA, has successfully raised $11 million in funding. The investment round closed on December 18, 2024, focusing on innovative therapies targeting cancers and immune disorders. More info: PeproMene Bio #Biotech#Funding#Cancer#ImmuneDisorders#California#ClinicalStage#Therapies#Investment#Healthcare#Innovation#PeproMeneBio#Pharmaceuticals#MedicalResearch#DrugDevelopment

Hashtags

#biotech #funding #cancer #immunedisorders #california #clinicalstage #therapies #investment #healthcare #innovation #pepromenebio #pharmaceuticals #medicalresearch #drugdevelopment